AstraZeneca CEO Expresses Optimism Over 'Very Encouraging' Lung Cancer Drug Trial

Positive Outlook: AstraZeneca CEO Praises Interim Data from Lung Cancer Drug Trial

AstraZeneca’s Chief Executive, Pascal Soriot, expressed optimism about the interim data from a crucial lung cancer drug trial. The trial…

Read More »